Key result
OSA-COPD overlap syndrome linked to ~21% higher in-hospital mortality versus OSA alone after PCI.
Why the study?
The impact of COPD and obesity hypoventilation syndrome in OSA patients undergoing PCI had never been studied.
Does the presence of concomitant COPD or obesity hypoventilation syndrome worsen clinical outcomes in patients with obstructive sleep apnea undergoing PCI?
Population
4,792,177 PCI-related inpatient encounters including 153,706 OSA, 65,135 OSA-COPD overlap, and 2,291 OSA+OHS patients
Comparison
OSA+OHS vs OSA-COPD overlap vs OSA alone
Design
Observational study using National Inpatient Sample (2007-2014)
Follow-up
In-hospital
Authors
Loading...
May warrant heightened periprocedural vigilance in OSA patients with COPD or obesity hypoventilation syndrome undergoing PCI; leaves open whether interventions modify outcomes.
Observational (n=4,792,177)
Yes
Does the presence of concomitant COPD or obesity hypoventilation syndrome worsen clinical outcomes in patients with obstructive sleep apnea undergoing PCI?
Odds Ratio: 1.21 (95% CI 1.11–1.32)
Absolute Event Rate: 1.5% vs 1.1%
p-value: p=<0.001
Concomitant obesity hypoventilation syndrome or COPD significantly increases the risk of in-hospital mortality, complications, and resource utilization in patients with obstructive sleep apnea undergoing PCI.
Desai et al. (2022) conducted an observational in Percutaneous coronary intervention with obstructive sleep apnea (n=4,792,177). OSA-COPD overlap syndrome vs. OSA alone was evaluated on All-cause in-hospital mortality (OR 1.21, 95% CI 1.11-1.32, p=<0.001). In patients undergoing percutaneous coronary intervention, concomitant OSA-COPD overlap syndrome significantly increased the odds of in-hospital mortality compared to OSA alone (OR 1.21), and OSA with obesity hypoventilation syndrome was associated with the highest unadjusted mortality (2.8% vs 1.1%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: